267 related articles for article (PubMed ID: 21444817)
1. Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone.
Börjesson AE; Windahl SH; Lagerquist MK; Engdahl C; Frenkel B; Movérare-Skrtic S; Sjögren K; Kindblom JM; Stubelius A; Islander U; Antal MC; Krust A; Chambon P; Ohlsson C
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6288-93. PubMed ID: 21444817
[TBL] [Abstract][Full Text] [Related]
2. The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice.
Börjesson AE; Farman HH; Engdahl C; Koskela A; Sjögren K; Kindblom JM; Stubelius A; Islander U; Carlsten H; Antal MC; Krust A; Chambon P; Tuukkanen J; Lagerquist MK; Windahl SH; Ohlsson C
J Bone Miner Res; 2013 May; 28(5):1117-26. PubMed ID: 23225083
[TBL] [Abstract][Full Text] [Related]
3. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.
Movérare-Skrtic S; Börjesson AE; Farman HH; Sjögren K; Windahl SH; Lagerquist MK; Andersson A; Stubelius A; Carlsten H; Gustafsson JÅ; Ohlsson C
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1180-5. PubMed ID: 24395795
[TBL] [Abstract][Full Text] [Related]
4. SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice.
Börjesson AE; Farman HH; Movérare-Skrtic S; Engdahl C; Antal MC; Koskela A; Tuukkanen J; Carlsten H; Krust A; Chambon P; Sjögren K; Lagerquist MK; Windahl SH; Ohlsson C
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E912-8. PubMed ID: 27048997
[TBL] [Abstract][Full Text] [Related]
5. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol.
Billon-Galés A; Fontaine C; Filipe C; Douin-Echinard V; Fouque MJ; Flouriot G; Gourdy P; Lenfant F; Laurell H; Krust A; Chambon P; Arnal JF
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2053-8. PubMed ID: 19188600
[TBL] [Abstract][Full Text] [Related]
6. Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1.
Farman HH; Wu J; Gustafsson KL; Windahl SH; Kim SH; Katzenellenbogen JA; Ohlsson C; Lagerquist MK
J Mol Endocrinol; 2017 Feb; 58(2):105-111. PubMed ID: 28057769
[TBL] [Abstract][Full Text] [Related]
7. The effects of estradiol are modulated in a tissue-specific manner in mice with inducible inactivation of ERα after sexual maturation.
Ohlsson C; Farman HH; Gustafsson KL; Wu J; Henning P; Windahl SH; Sjögren K; Gustafsson JÅ; Movérare-Skrtic S; Lagerquist MK
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E646-E654. PubMed ID: 32125882
[TBL] [Abstract][Full Text] [Related]
8. Roles of activating functions 1 and 2 of estrogen receptor α in lymphopoiesis.
Andersson A; Törnqvist AE; Moverare-Skrtic S; Bernardi AI; Farman HH; Chambon P; Engdahl C; Lagerquist MK; Windahl SH; Carlsten H; Ohlsson C; Islander U
J Endocrinol; 2018 Feb; 236(2):99-109. PubMed ID: 29255084
[TBL] [Abstract][Full Text] [Related]
9. The AF-1 activation function of estrogen receptor α is necessary and sufficient for uterine epithelial cell proliferation in vivo.
Abot A; Fontaine C; Raymond-Letron I; Flouriot G; Adlanmerini M; Buscato M; Otto C; Bergès H; Laurell H; Gourdy P; Lenfant F; Arnal JF
Endocrinology; 2013 Jun; 154(6):2222-33. PubMed ID: 23580568
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-α is required for the osteogenic response to mechanical loading in a ligand-independent manner involving its activation function 1 but not 2.
Windahl SH; Saxon L; Börjesson AE; Lagerquist MK; Frenkel B; Henning P; Lerner UH; Galea GL; Meakin LB; Engdahl C; Sjögren K; Antal MC; Krust A; Chambon P; Lanyon LE; Price JS; Ohlsson C
J Bone Miner Res; 2013 Feb; 28(2):291-301. PubMed ID: 22972752
[TBL] [Abstract][Full Text] [Related]
11. Activation function 2 (AF2) domain of estrogen receptor-α regulates mechanotransduction during bone fracture healing in estrogen-competent mice.
Steppe L; Krüger B; Tschaffon-Müller MEA; Ramge JM; Schoppa A; Ignatius A; Haffner-Luntzer M
Bone; 2023 Jul; 172():116781. PubMed ID: 37100360
[TBL] [Abstract][Full Text] [Related]
12. Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable.
Handgraaf S; Riant E; Fabre A; Waget A; Burcelin R; Lière P; Krust A; Chambon P; Arnal JF; Gourdy P
Diabetes; 2013 Dec; 62(12):4098-108. PubMed ID: 23903353
[TBL] [Abstract][Full Text] [Related]
13. The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice.
Börjesson AE; Windahl SH; Karimian E; Eriksson EE; Lagerquist MK; Engdahl C; Antal MC; Krust A; Chambon P; Sävendahl L; Ohlsson C
Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1381-9. PubMed ID: 22414805
[TBL] [Abstract][Full Text] [Related]
14. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways.
Syed FA; Mödder UI; Fraser DG; Spelsberg TC; Rosen CJ; Krust A; Chambon P; Jameson JL; Khosla S
J Bone Miner Res; 2005 Nov; 20(11):1992-2001. PubMed ID: 16234973
[TBL] [Abstract][Full Text] [Related]
15. The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells.
Henning P; Ohlsson C; Engdahl C; Farman H; Windahl SH; Carlsten H; Lagerquist MK
Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E589-95. PubMed ID: 25117411
[TBL] [Abstract][Full Text] [Related]
16. Arginine site 264 in murine estrogen receptor-α is dispensable for the regulation of the skeleton.
Gustafsson KL; Farman HH; Nilsson KH; Henning P; Movérare-Skrtic S; Lionikaite V; Lawenius L; Engdahl C; Ohlsson C; Lagerquist MK
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E160-E168. PubMed ID: 33225718
[TBL] [Abstract][Full Text] [Related]
17. The genomic regulatory elements for estrogen receptor alpha transactivation-function-1 regulated genes.
Arao Y; Hamilton KJ; Grimm SA; Korach KS
FASEB J; 2020 Dec; 34(12):16003-16021. PubMed ID: 33064339
[TBL] [Abstract][Full Text] [Related]
18. ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.
Gustafsson KL; Nilsson KH; Farman HH; Andersson A; Lionikaite V; Henning P; Wu J; Windahl SH; Islander U; Movérare-Skrtic S; Sjögren K; Carlsten H; Gustafsson JÅ; Ohlsson C; Lagerquist MK
J Endocrinol; 2018 Aug; 238(2):129-136. PubMed ID: 29848607
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
Arao Y; Hamilton KJ; Coons LA; Korach KS
J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
[TBL] [Abstract][Full Text] [Related]
20. Female Mice Lacking Estrogen Receptor-α in Hypothalamic Proopiomelanocortin (POMC) Neurons Display Enhanced Estrogenic Response on Cortical Bone Mass.
Farman HH; Windahl SH; Westberg L; Isaksson H; Egecioglu E; Schele E; Ryberg H; Jansson JO; Tuukkanen J; Koskela A; Xie SK; Hahner L; Zehr J; Clegg DJ; Lagerquist MK; Ohlsson C
Endocrinology; 2016 Aug; 157(8):3242-52. PubMed ID: 27254004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
